Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ampreloxetine in Fibromyalgia
NCT01693692Phase 2Completed
- Sponsor
- Theravance Biopharma, Inc.
- Start
- Nov 2012
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ampreloxetine in fibromyalgia (FM), sponsored by Theravance Biopharma, Inc.. Started Nov 2012; status: completed.
02
Drugs
ampreloxetine
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT01693692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01693692.